In a previous study, we demonstrated that dysadherin enhances cancer cell adhesion to fibronectin, thereby activating integrin/FAK signaling.27 IPA analysis identified STAT3 as a downstream effector of the integrin/FAK pathway38 (Fig. 4a). The gene discussed is FXYD5; the disease is cancer.